Terapevticheskii Arkhiv · Aug 27, 2026
“Double Diabetes”: Is it time to revise the classification?
By Shestakova MV, Vikulova OK, Efremova SA
Double diabetes is a clinical phenotype arising from the combination of autoimmune type 1 diabetes mellitus (T1 DM) with insulin resistance, obesity, and other components of the metabolic syndrome. The growing prevalence of overweight and obesity among patients with T1 DM, including at disease onset, makes double diabetes an increasingly relevant clinical problem and raises the question of its place within the classification of hybrid forms of diabetes. This review covers current evidence on the epidemiology, pathogenesis, diagnosis, clinical consequences, and therapeutic approaches in double diabetes. Key mechanisms of its development are discussed, including the effects of insulin therapy and lifestyle factors, genetic predisposition to insulin resistance, chronic subclinical inflammation, adipokine dysfunction, and β-cell stress. Three developmental scenarios are presented: the superimposition of insulin resistance on long-standing T1 DM, the onset of autoimmune diabetes in individuals with pre-existing obesity, and the debated hypothesis of autoimmune transformation of long-duration T2 DM. Double diabetes is shown to be associated with an increased risk of micro- and macrovascular complications independent of HbA1c levels. In clinical practice, estimation of the glucose disposal rate (eGDR) serves as a key accessible marker of insulin resistance for identifying high-risk patients. The authors conclude that unified diagnostic criteria for double diabetes are needed, along with its more explicit recognition in future diabetes classifications. Therapeutic strategies are based on mandatory insulin therapy combined with correction of obesity and cardiometabolic risk; the potential of metformin, SGLT2 inhibitors, GLP-1 receptor agonists, and dual GLP-1/GIP agonists as add-on therapy is discussed, considering the elevated risk of diabetic ketoacidosis and limited long-term safety data.